ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice - April 19, 2024

SAN MATEO, Calif. and SINGAPORE - ASLAN Pharmaceuticals , a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today...

Related Keywords

United States ,California ,Singapore ,American ,Emma Thompson ,Ashleyr Robinson ,Linkedin ,Letter For The Company ,Spurwing Communications ,Company Annual Report On Form ,Exchange Commission ,Pharmaceuticals Nasdaq ,Company Form ,Commission File No ,Company American Depositary ,Nasdaq ,Lifesci Advisors ,Nasdaq Stock Market ,Nasdaq Listing Rule ,Nasdaq Capital Market ,Stockholder Equity Requirement ,Stockholder Equity ,American Depositary Shares ,Commission File ,Annual Report ,Sci Advisors ,News Publishing ,Markets ,